Dana-Farber Raises $1.2B with Focus on Personalized Cancer Treatment | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Dana-Farber Cancer Institute said today that it has raised about $1.2 billion to conclude the largest capital campaign in its history — a seven-year drive whose proceeds helped establish several centers focused on developing personalized cancer care.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.